Latest radiopharmaceuticals Stories
TORONTO, Oct. 8, 2012 /PRNewswire/ -- Mobile Integrated Systems, Inc. ("MIBI") announced the execution of an implementation and cloud-based operations contract (the "Agreement") with lottery operator Movil Game Solutions C.A. ("the Operator") for SMS-based mobile phone lottery infrastructure. The MIBI solution is based on the MobiLotto family of cloud-based products developed by MIBI. "We are delighted to have been chosen by Movil Game Solutions C.A. to launch this exciting...
LUBBOCK, Texas, Sept. 27, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a molecular imaging healthcare company will be presenting at the 1(st) International Business Conference for Producers, Suppliers and Consumers of Isotope Products (1IBCI), which will take place in Moscow, Russia, October 1(st )- 3(rd), 2012. The 1IBCI conference, organized by Isotope Co., an entity within the Rosatom State Atomic Energy Corporation's (ROSATOM) Program "Radiation Technologies," will...
FARMINGTON, Conn., Sept. 24, 2012 /PRNewswire-iReach/ -- As the medical imaging industry approaches maturity in developed markets, imaging machine makers such as GE and Siemens AG are looking to bolster significant growth in the developing markets. Nontraditional uses for diagnostics and monitoring for both new therapies and minimally invasive procedures is expected to drive growth in the U.S., reports The Wall Street Journal. The market for contrast agents and radiopharmaceuticals is also...
DULLES, Va., Sept. 10, 2012 /PRNewswire/ -- IBA Molecular North America, Inc. (IBA Molecular), a leading manufacturer and distributor of PET imaging tracers, has announced the introduction of its Centers for Innovation, two unique facilities designed for advanced radiopharmaceutical contract development and manufacturing. The centers are located in Totowa and Somerset, New Jersey. Complementing these sites are IBA Molecular's production capabilities for isotopes such as I-124, F-18,...
BALTIMORE, Sept. 6, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), - is pleased to announce that Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, and Positron Corporation (hereinafter "Positron"), have executed a Letter of Intent pertaining to: (a) Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator; (b) JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to...
DANA POINT, Calif., June 5, 2012 /PRNewswire/ -- Fashion Destination Group (FDG) and Working Wardrobes is proud to announce that "TRUE BLOOD" star Stephanie Erb will be joining Catt Saddler in hosting the inaugural Fashion Destination Summer Soiree at the St. Regis Resort Hotel in beautiful Dana Point. Stephanie is best known for her recent role as Luellen, a witch in Marnie's coven. FDG wanted to spotlight the best companies in the Orange County Fashion and Lifestyle category by...
Canadian centre of excellence partners with US-based Molecular Insight Pharmaceuticals to manufacture a new radiopharmaceutical for clinical trials that will evaluate the potential to deliver targeted radiotherapy directly to metastatic prostate cancer. HAMILTON, ON, and CAMBRIDGE, MA, Jan. 30, 2012 /PRNewswire/ - A new targeted radiopharmaceutical, designed to deliver a therapeutic dose of radiation directly to metastatic prostate cancer, will be manufactured in Hamilton,...
DALLAS, August 10, 2011 /PRNewswire/ --The report "Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) - Current Trends & Forecasts (2010 - 2015) [http://www.marketsandmarkets.com/Market-Reports/radiopharmaceuticals-market-417.html ] " analyzes the market for radiopharmaceuticals by isotopes, routes of administration, and applications; and studies the major market drivers, restraints, opportunities, and market trends for radiopharmaceuticals market...
SALT LAKE CITY, July 8, 2011 /PRNewswire/ -- Garb Oil & Power Corporation ("Garb") (OTCQB: GARB) has completed its due diligence and has made an offer to buy FDG di Collu S.r.l., and Carbus S.r.l., for euro 10,500,000. Upon review of the offer FDG di Collu S.r.l., and Carbus S.r.l., rejected the offer as too low. Further negotiations did not resolve the issue. In consideration of the above Garb's board has informed FDG and Carbus that Garb has terminated negotiations to acquire FDG and...
BERLIN, November 23, 2010 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG). FDG is used in the context of the so called Positron Emission...
